Health Science Report
Site Navigation



Research that helps:



Home

  >

Cervical Dysplasia

>

Cervical Cancer

>

Cervical Cancer Vaccine

Cervical Cancer Vaccine

Cervical cancer vaccine r&d targets ways to block viral propagation; current treatment targets genital condyloma or wart removal, not the virus. Testing for cancerous cells of the cervix is done through a Pap smear. It is important to have your annual exam to detect any symptoms of future cancerous tissue or cells, because early detection is key to successful treatment and helps avoid complications. After the age of 30 a combination of Pap smear and HPV test should be performed. Cervical cancer vaccine r&d targets ways to block viral propagation; current treatment targets genital condyloma or wart removal, not the virus.

Just select from the Research Topics on the adjacent gray column for easy viewing of important articles. If this is your first visit, click here for a brief summary of this website.

.

Cervical Cancer Vaccine

  -  

Condyloma, Wart

Most of women achieve immunity to abnormal cells of the cervix within 9-18 months. Once this immunity is achieved, then they cannot be reinfected, nor transmit this particular strain. Still, they are susceptible to other strains of HPV. Cervical cancer vaccine r&d targets ways to block viral propagation; current treatment targets genital condyloma or wart removal, not the virus.

Other Topics: HPV, HPV Vaccination, HPV Virus, HPV Vaccine Merck, Epidemiology of HPV, Human Papillomavirus, Cervical Cancer Human Papilloma Virus, Cervix Cancer, Pap Smear, Genital Wart

Dr. Joe Glickman, Jr., M.D.

BBBOnLine Reliability Seal

Copyright © 1996-2009 by Health Science Report™ for the following: